722 Stories, most recent news story added 58 minutes ago
Although seen as a potential heart disease therapy, raising high-density lipoprotein cholesterol levels by inhibiting activity of a transfer protein may not be effective, a new study suggests. Scientists found an association between low plasma cholesterol ester transfer protein activity and increased risk of heart disease in the Framingham Heart Study population.
Although seen as a potential heart disease therapy, raising high-density lipoprotein (HDL) cholesterol levels by inhibiting activity of a transfer protein may not be effective, a new study suggests. Scientists at Tufts University and Boston University School of Medicine found an association between low plasma cholesterol ester transfer protein (CETP) activity and increased risk of heart disease ...
An unpublished German study shows higher incidence of strokes and other cardiovascular problems among people who live near airports
The panel has endorsed expanded use of the cholesterol pill to prevent heart disease, a move that could add $500 million to annual sales.
Dec. 11 (Bloomberg) -- AstraZeneca Plc’s Crestor may prevent heart disease in people with normal cholesterol, and not just in those who suffer from high lipid levels, according to U.S. regulators evaluating whether to expand use of the medicine.
AstraZeneca won a U.S. panel's support on Tuesday for its bid to promote the cholesterol-lowering pill Crestor to people with healthy cholesterol levels but have other risks of heart disease.
In Health Watch:Women are at risk of developing heart disease after menopau read more
New findings published in the Dec. 15-22, 2009, Prevention and Outcomes Focus Issue of the Journal of the American College of Cardiology aim to disentangle the influence of menopause versus chronological aging in upping women's post-menopausal risk for heart disease, evaluate the role of smoking status, physical activity and diet-induced weight loss in certain patient populations, and more fully ...
Cardiomyopathy, a weakening of the heart muscle often associated with inadequate heart pumping, affects tens of thousands of people in the United States. Researchers have discovered a new molecular pathway controlled by a master-switch protein in the heart muscles called myocardin that may be key to understanding some forms of heart disease. This pathway links heart muscle structure to heart ...
Heart disease is the nation's leading cause of death. What can you do to reduce the risk of heart disease?
Heart disease is the No. 1 killer in the United States. According to the CDC, "About every 25 seconds, an American will have a coronary event, and about one every minute will die from one." One per minute works out to more than half a million people dead from heart problems per year.
Open slideshowAFP/File
Open slideshowAFP/File
Open slideshowAFP/File
Open slideshowIntermountain Healthcare
Open slideshowAFP/HO/File